|

Radiosensitizing Agent Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Radiation Sensitizers, Radiation-Sensitizing Agents, Radiation-Sensitizing Drugs, Radiosensitizers, Radiosensitizing Drugs +1 more

Pipeline

Phase 1/2: 1

Top Sponsors

  • University of Washington1

Indications

  • Stage IV Bladder Cancer AJCC v81
  • Stage III Bladder Cancer AJCC v81
  • Muscle-Invasive Bladder Carcinoma1
  • Cancer1

Seattle, Washington1 trial

Consolidative Therapy After EV + Pembrolizumab in Muscle Invasive Bladder Cancer, REINFORCE Trial

Fred Hutch/University of Washington Cancer Consortium

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.